Microfluidic Lipid Nanoparticle Mixing for Size and Encapsulation Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods struggle to control the size and composition of lipid nanoparticles for nucleic acid delivery due to spontaneous aggregation of phospholipids and cholesterol, leading to non-uniform particle formation and inefficient encapsulation.
Innovation Solution
A microfluidic device with specific design features, including multiple inlet channels, a mixing channel with microposts, and controlled fluid flow directions, allows for precise regulation of molar ratios and Reynolds numbers to produce lipid nanoparticles of varying sizes with high efficiency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If cholesterol is included in lipid nanoparticles to improve drug loading efficiency and particle stability, then the fluidity of the biomembrane decreases and binding between phospholipids becomes stronger, but it becomes difficult to produce uniform lipid nanoparticles and control their size
Solution Approach 1:
The patent adjusts the molar ratio of cholesterol to phospholipids as a key parameter to control nanoparticle size and uniformity. By optimizing this composition parameter, the patent achieves both high particle stability (from cholesterol's membrane-strengthening effect) and controlled size uniformity (by preventing excessive aggregation). The patent specifically explores different cholesterol ratios to find the optimal balance between stability and size control.
2Ease of manufacture
If conventional methods are used to prepare lipid nanoparticles, then the process is simple, but nanoparticles of different sizes such as micelles and liposomes are formed due to spontaneous aggregation
Solution Approach 1:
The patent performs preliminary action by pre-mixing lipids and cholesterol in specific molar ratios before nanoparticle formation. This pre-positioning of components in optimized proportions prevents random aggregation during the self-assembly process, ensuring uniform particle sizes while maintaining procedural simplicity. The patent prepares lipid mixtures with predetermined compositions that guide the formation of monodisperse nanoparticles.
3Reliability
If high cholesterol content is used to reduce nucleic acid leakage, then encapsulation efficiency improves for short sequences, but it becomes excessively high for long sequences like mRNA
Solution Approach 1:
The patent applies dynamics by making the cholesterol content adjustable and optimized based on the specific nucleic acid payload. Rather than using a fixed high cholesterol ratio, the patent dynamically adapts the lipid composition to match the requirements of different nucleic acid lengths - using higher cholesterol ratios for short sequences that need leakage prevention, and lower ratios for long mRNA sequences that require flexibility. This dynamic optimization achieves both high encapsulation efficiency and versatility across different therapeutic nucleic acids.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves controlled particle size and high encapsulation efficiency of nucleic acids, with polydispersity index (PDI) of 0.3 or less and encapsulation efficiency of 50% or more, enhancing therapeutic delivery efficiency.
Implementation Method 1
The mixing channel may include microposts... adjusting the Reynolds number... efficient mixing in the production of lipid nanoparticles
Implementation Method 2
injecting a lipid mixture into the inlet channel... injecting nucleic acid into another inlet channel... mixing a lipid mixture and nucleic acid in the mixing channel
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The present invention relates to a microfluidic device for preparing lipid nanoparticles capable of delivering nucleic acids, and a method for preparing lipid nanoparticles using the same. Using the microfluidic device, lipid nanoparticles having a desired size can be prepared by adjusting the molar ratio of compositions and the Reynolds number.